Literature DB >> 2541379

[High-frequency atrial arrhythmia induced by a cisplatin-etoposide combination].

V Petrella1, P Alciato, P A Cantone, D Fico, R Gagliardini.   

Abstract

The cardiotoxicity of cytostatic drugs reported in the literature is marked for some (adriamycin), rather rare for others. Cases of angina, infarction, and atrial arrhythmia have been reported during treatment with cisplatin. The case is reported of a 65-year-old patient with no risk factors for cardiovascular disease who had two attacks of high-frequency atrial arrhythmia during combined treatment with cisplatin and etoposide. The first attack came after the first cycle and disappeared spontaneously; the second, after the second cycle, required antiarrhythmic treatment. The potential myocardial toxicity of cisplatin, especially when combined with other potentially cardiotoxic drugs or administered after cycles of adriamycin is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541379

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  4 in total

1.  Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.

Authors:  T Schilling; K B Keppler; M E Heim; G Niebch; H Dietzfelbinger; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Review of cardiotoxicity in pediatric cancer patients: during and after therapy.

Authors:  Joy M Fulbright
Journal:  Cardiol Res Pract       Date:  2011-05-23       Impact factor: 1.866

3.  Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.

Authors:  Harshal Nemade; Umesh Chaudhari; Aviseka Acharya; Jürgen Hescheler; Jan Georg Hengstler; Symeon Papadopoulos; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2018-02-03       Impact factor: 5.153

Review 4.  Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms.

Authors:  Xinyu Yang; Xinye Li; Mengchen Yuan; Chao Tian; Yihan Yang; Xiaofeng Wang; Xiaoyu Zhang; Yang Sun; Tianmai He; Songjie Han; Guang Chen; Nian Liu; Yonghong Gao; Dan Hu; Yanwei Xing; Hongcai Shang
Journal:  Front Pharmacol       Date:  2018-10-16       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.